289 related articles for article (PubMed ID: 22761400)
1. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers.
Kikuchi T; Hassanein M; Amann JM; Liu Q; Slebos RJ; Rahman SM; Kaufman JM; Zhang X; Hoeksema MD; Harris BK; Li M; Shyr Y; Gonzalez AL; Zimmerman LJ; Liebler DC; Massion PP; Carbone DP
Mol Cell Proteomics; 2012 Oct; 11(10):916-32. PubMed ID: 22761400
[TBL] [Abstract][Full Text] [Related]
2. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.
Codreanu SG; Hoeksema MD; Slebos RJC; Zimmerman LJ; Rahman SMJ; Li M; Chen SC; Chen H; Eisenberg R; Liebler DC; Massion PP
J Proteome Res; 2017 Sep; 16(9):3266-3276. PubMed ID: 28731711
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.
Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG
Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422
[TBL] [Abstract][Full Text] [Related]
4. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
[TBL] [Abstract][Full Text] [Related]
5. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
[TBL] [Abstract][Full Text] [Related]
6. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of non-small cell lung carcinoma by circulating microRNA.
Singh A; Kant R; Saluja TS; Tripathi T; Srivastava K; Naithani M; Gupta A; Mirza AA; Prakash V; Singh SK
J Cancer Res Ther; 2020; 16(1):127-131. PubMed ID: 32362622
[TBL] [Abstract][Full Text] [Related]
9. Protein expression in human non-small cell lung cancer: a systematic database.
Bührens RI; Amelung JT; Reymond MA; Beshay M
Pathobiology; 2009; 76(6):277-85. PubMed ID: 19955839
[TBL] [Abstract][Full Text] [Related]
10. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.
Ma Z; Li H; Wang B; Shen Q; Cui E; Min L; Qian F; Ping J; Dai L
J Cancer Res Clin Oncol; 2013 Apr; 139(4):557-62. PubMed ID: 23224432
[TBL] [Abstract][Full Text] [Related]
11. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology.
Pan J; Chen HQ; Sun YH; Zhang JH; Luo XY
Lung; 2008; 186(4):255-261. PubMed ID: 18465169
[TBL] [Abstract][Full Text] [Related]
13. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
[TBL] [Abstract][Full Text] [Related]
14. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.
Sun L; Chen L; Sun L; Pan J; Yu L; Han L; Yang Z; Luo Y; Ran Y
Mol Cell Proteomics; 2013 Feb; 12(2):395-406. PubMed ID: 23184915
[TBL] [Abstract][Full Text] [Related]
15. PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics.
Gámez-Pozo A; Sánchez-Navarro I; Calvo E; Agulló-Ortuño MT; López-Vacas R; Díaz E; Camafeita E; Nistal M; Madero R; Espinosa E; López JA; Fresno Vara JÁ
PLoS One; 2012; 7(3):e33752. PubMed ID: 22461895
[TBL] [Abstract][Full Text] [Related]
16. Roles of immunohistochemical staining in diagnosing pulmonary squamous cell carcinoma.
Yan Y; Zhang YX; Fang WF; Kang SY; Zhan JH; Chen N; Hong SD; Liang WH; Tang YN; He DC; Wu X; Zhang L
Asian Pac J Cancer Prev; 2015; 16(2):551-7. PubMed ID: 25684486
[TBL] [Abstract][Full Text] [Related]
17. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
[TBL] [Abstract][Full Text] [Related]
18. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
Qu Y; Yang Y; Ma D; Xiao W
Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423
[TBL] [Abstract][Full Text] [Related]
19. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of non-small cell lung cancer tissue interstitial fluids.
Li S; Wang R; Zhang M; Wang L; Cheng S
World J Surg Oncol; 2013 Aug; 11():173. PubMed ID: 23914992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
